Can a simple shunt help liver cancer patients live longer?
NCT ID NCT07365930
Summary
This study is observing whether a procedure called TIPS, which creates a shunt to relieve pressure in the liver, helps patients with advanced liver cancer. The goal is to see if this procedure allows patients to better tolerate and potentially get more benefit from their standard immunotherapy drugs (atezolizumab and bevacizumab). Researchers will track 350 patients in Germany to see if the shunt improves liver function, survival, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Düsseldorf
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.